Search

Author/Creator Nickles, Dorothee

1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Issue 10031 (7th May 2016)

Authors:
Rosenberg, Jonathan E; Hoffman-Censits, Jean; Powles, Tom; van der Heijden, Michiel S; Balar, Arjun V; Necchi, Andrea; Dawson, Nancy; O'Donnell, Peter H; Balmanoukian, Ani; Loriot, Yohann; Srinivas, Sandy; Retz, Margitta M; Grivas, Petros; Joseph, Richard W; Galsky, Matthew D; Fleming, Mark T; Pe...
Journal:
Lancet
Issue:
Volume 387:Issue 10031(2016)
Page Start:
1909
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). (4th November 2015)

Authors:
Powles, Thomas; Nickles, Dorothee; Van Allen, Eliezer; Chappey, Colombe; Zou, Wei; Kowanetz, Marcin; Kadel, Edward; Denker, Mitchell; Boyd, Zachary; Vogelzang, Nicholas; Kim, Joseph; Bellmunt, Joaquim; Loriot, Yohann; Drake, Charles G; O'Hear, Carol; Fasso, Marcella; Hegde, Priti; Mariathasan, Sa...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Issue 2 (December 2015)

Authors:
Powles, Thomas; Nickles, Dorothee; Van Allen, Eliezer; Chappey, Colombe; Zou, Wei; Kowanetz, Marcin; Kadel, Edward; Denker, Mitchell; Boyd, Zachary; Vogelzang, Nicholas; Kim, Joseph; Bellmunt, Joaquim; Loriot, Yohann; Drake, Charles; O'Hear, Carol; Fasso, Marcella; Hegde, Priti; Mariathasan, Sanjeev
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. (December 2018)

Authors:
McDermott, David; Huseni, Mahrukh; Atkins, Michael; Motzer, Robert; Rini, Brian; Escudier, Bernard; Fong, Lawrence; Joseph, Richard; Pal, Sumanta; Reeves, James; Sznol, Mario; Hainsworth, John; Rathmell, W.; Stadler, Walter; Hutson, Thomas; Gore, Martin; Ravaud, Alain; Bracarda, Sergio; Suárez, C...
Journal:
Nature medicine
Issue:
Volume 24:Number 12(2018)
Page Start:
1941
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗